2Nichol PF,Starling JR,Mack E,et al.Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma[J].Ann Surg,2002,235(5):673-680. 被引量：1
3Ahmad R,Hammond JM.Primary secondary,and tertiary hyperparathyroidism[J].Otolaryngol Clin N Am,2004,37(4):701-713. 被引量：1
8Schachter PP,Issa N,Shimonov M et al.Early postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy[J].Arch Surg,2004,139(4):433-437. 被引量：1
9Sfakianakis GN,Irvin GL 3rd,Foss J,et al.Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements[J].J Nucl Med,1996,37:798-804. 被引量：1
4Kerby JD, Rue LW, Blair H,et al. Operative treatment of tertiary hyperparathyroidism. Ann Surg, 1998,227:878-886. 被引量：1
5Diethelm Alessandro AM, Melzer JS, Pirsch JD, et al. Tertiary hyperparathyroidism after renal transplantation:Operative indication. Surgery, 1989,106 : 1049-1056. 被引量：1
6Kilgo MS, Pirsch JD, Warner TK, et al. Tertiary hyperparathyroidis mafter renal transplantation : surgical strategy. Surgery, 1998,124:677-684. 被引量：1
7Kinnaert P, Nagy N, Decoster-Gervy C, Persistent hyerparathyroidism requiring surgical treatment after kidney transplantation. World J Surg,2000,24 : 1391-1395. 被引量：1
8Falchetti A, Bale AE, Amorosi A, et al. Progression of uremic hyperparathyroidism involoves allelic loss on chromosome 11. J Clin Endocrinol Metab, 1993,76 : 139-144. 被引量：1
9Kifor O, Moore FD, Wang P,et al. Reduced immuno-staining for the extracellular Ca^2 + -sensing receptor in primary and uremic secondary hyperparathyroidism. J Clinic Endo and Metab, 1996, 81 : 1598-1606. 被引量：1
10Edis AJ, Levitt MD. Supermumerary parathyroid glands:implications for the surgical treatment of secondary hyperparathyroidism. World J Surg, 1987,11:398- 401. 被引量：1
